Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

640
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
640
Tissue Transplantation01:24

Tissue Transplantation

1.2K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.2K
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

652
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
652
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

2.2K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.2K
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

488
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
488
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

85.7K
Overview
85.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of Cancer Cases Reported through Inter-Registry Data Exchange in New York State.

Journal of registry management·2026
Same author

Under-enrollment in rare kidney disease trials: lessons learned from the PRIVENT recurrent FSGS.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same author

Adult T-Cell Leukemia/Lymphoma and Targeted Maternal Screening.

JAMA oncology·2026
Same author

Census tract-level socioeconomic variables and breast cancer characteristics and outcomes in California and New York State.

Cancer causes & control : CCC·2026
Same author

Population-level cancer trends among solid organ transplant recipients in the United States during 1995-2021.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same author

Evaluating mammographic density polygenic risk score for contralateral breast cancer risk prediction.

Scientific reports·2026

Related Experiment Video

Updated: Mar 13, 2026

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
11:49

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

16.7K

Cancer Risk in Solid Organ Transplant Recipients With a Pretransplant Cancer History.

Jun Tao1, Ruth M Pfeiffer1, Shyfuddin Ahmed1

  • 1Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

JAMA Oncology
|March 12, 2026
PubMed
Summary

Solid organ transplant recipients with a prior cancer diagnosis face a higher risk of developing subsequent cancers, especially of the same type. This highlights the need for targeted cancer screening and prevention strategies in this population.

More Related Videos

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

15.0K
Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

7.8K

Related Experiment Videos

Last Updated: Mar 13, 2026

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
11:49

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

16.7K
In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

15.0K
Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

7.8K

Area of Science:

  • Oncology
  • Transplant Medicine
  • Epidemiology

Background:

  • Cancer survivors have an increased risk of subsequent cancers.
  • Solid organ transplant (SOT) recipients have a higher risk of cancer.
  • The subsequent cancer risk in SOT recipients with a history of cancer is not well understood.

Purpose of the Study:

  • To investigate the association between pretransplant cancers and posttransplant cancer risk in SOT recipients.
  • To compare posttransplant cancer risk in SOT recipients with and without a history of cancer.
  • To evaluate if pretransplant cancer patterns predict posttransplant cancer development.

Main Methods:

  • A cohort study utilizing linked data from the US Scientific Registry of Transplant Recipients and 34 population-based cancer registries (1995-2019).
  • Inclusion of 520,424 SOT recipients.
  • Analysis of 581 pretransplant and posttransplant cancer combinations using incidence rate ratios (IRRs) adjusted for age, sex, and transplanted organ.

Main Results:

  • SOT recipients with pretransplant cancer had an elevated risk of posttransplant cancer (IRR > 1.0).
  • Seven pretransplant cancers showed a significant association with the same cancer type post-transplant, including breast, melanoma, lung, kidney, bladder, liver, and colorectum.
  • Specific cancer sequences were identified, such as liver followed by lung or prostate cancer.
  • IRRs for liver-liver, kidney-kidney, and lung-lung posttransplant cancers were lower than general population standardized incidence ratios (SIRs).

Conclusions:

  • Pretransplant cancer significantly increases the risk of posttransplant cancer in SOT recipients, particularly for the same cancer type.
  • Shared genetic or environmental factors likely contribute to these associations.
  • End-stage organ disease may play a role in specific organ-cancer sequences (e.g., kidney, liver, lung).
  • Targeted cancer prevention and screening are crucial for SOT recipients with a history of cancer.